Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 2
1983 1
1984 1
1987 1
1988 2
1990 1
2008 1
2013 1
2016 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

11 results
Results by year
Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Alclometasone dipropionate in psoriasis: a clinical study.
Aggerwal A, Maddin S. Aggerwal A, et al. J Int Med Res. 1982;10(6):414-8. doi: 10.1177/030006058201000605. J Int Med Res. 1982. PMID: 7152079 Clinical Trial.
In a parallel group design, and using a 'blind evaluator' technique, alclometasone cream 0.05% and clobetasone butyrate cream 0.5% applied twice a day for 21 days were compared in thirty-one patients presenting with psoriasis. ...No adverse experience was reported and the …
In a parallel group design, and using a 'blind evaluator' technique, alclometasone cream 0.05% and clobetasone butyrate cream 0.5% ap …
Alclometasone dipropionate cream 0.05% versus clobetasone butyrate cream 0.05%. A controlled clinical comparison in the treatment of atopic dermatitis in children.
Lassus A. Lassus A. Int J Dermatol. 1984 Oct;23(8):565-6. doi: 10.1111/j.1365-4362.1984.tb04214.x. Int J Dermatol. 1984. PMID: 6389385 Clinical Trial.
At the end of the trial, average reduction in disease signs was 85% for alclometasone dipropionate-treated patients and 86% in the clobetasone butyrate-treated group. In the global evaluation, the physician rated symptoms as cleared in 9 of 22 alclometasone dipropio …
At the end of the trial, average reduction in disease signs was 85% for alclometasone dipropionate-treated patients and 86% in the cl …
Clinical comparison of alclometasone dipropionate cream 0.05% with hydrocortisone butyrate cream 0.1% in the treatment of atopic dermatitis in children.
Lassus A. Lassus A. J Int Med Res. 1983;11(5):315-9. doi: 10.1177/030006058301100512. J Int Med Res. 1983. PMID: 6357892 Clinical Trial.
Both creams were effective treatments for atopic dermatitis; however, alclometasone dipropionate was judged slightly more efficacious. Improvement in erythema, induration, and pruritus averaged 76% for alclometasone dipropionate-treated patients and 70% for hydrocor …
Both creams were effective treatments for atopic dermatitis; however, alclometasone dipropionate was judged slightly more efficacious …
Clinical comparison of alclometasone dipropionate and desonide ointments (0.05%) in the management of psoriasis.
Frost P, Horwitz SN. Frost P, et al. J Int Med Res. 1982;10(5):375-8. doi: 10.1177/030006058201000511. J Int Med Res. 1982. PMID: 6754511 Clinical Trial.
This was a double-blind, randomized, parallel-groups comparison of alclometasone dipropionate and desonide ointments (0.05%) applied twice daily without occlusion for 3 weeks by patients with moderate to severe psoriasis. ...Differences between the groups were not statisti …
This was a double-blind, randomized, parallel-groups comparison of alclometasone dipropionate and desonide ointments (0.05%) applied …
Alclometasone dipropionate 0.05% vs hydrocortisone 1.0%: potential to induce cutaneous atrophy in children.
Kuokkanen K, Sillantaka I. Kuokkanen K, et al. Clin Ther. 1987;9(2):223-31. Clin Ther. 1987. PMID: 3568065 Clinical Trial.
Alclometasone dipropionate 0.05% and hydrocortisone 1.0% ointments were applied twice daily for three weeks to bilateral, paired eczematous lesions of children. ...After three weeks of therapy, improvement in the total score of ratings of the severity of signs and symptoms …
Alclometasone dipropionate 0.05% and hydrocortisone 1.0% ointments were applied twice daily for three weeks to bilateral, paired ecze …
[Alclometasone dipropionate (Legederm) for the treatment of steroid-sensitive dermatoses in the elderly].
Morresi A, Simonacci M, Mozzicafreddo G, Giacchetti A, Criante P, Mambelli V, Sisti S, Marchesi E. Morresi A, et al. G Ital Dermatol Venereol. 1990 Jun;125(6):XXIII-XXVII. G Ital Dermatol Venereol. 1990. PMID: 2279745 Clinical Trial. Italian.
This is a randomized single blind parallel comparison of alclometasone dipropionate cream 0.1% vs hydrocortisone butyrrate in 39 geriatric patients (greater than 60 years old) with steroid sensible skin diseases. ...Fluctuations of blood cortisol levels ranged between the …
This is a randomized single blind parallel comparison of alclometasone dipropionate cream 0.1% vs hydrocortisone butyrrate in 39 geri …
Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
Paller AS, Eichenfield LF, Kirsner RS, Shull T, Jaracz E, Simpson EL; US Tacrolimus Ointment Study Group. Paller AS, et al. Pediatrics. 2008 Dec;122(6):e1210-8. doi: 10.1542/peds.2008-1343. Epub 2008 Nov 17. Pediatrics. 2008. PMID: 19015204 Clinical Trial.
RESULTS: Of 206 randomly assigned patients, 152 completed Phase I; 105 of 152 were randomly assigned into Phase II (68 tacrolimus ointment and 37 vehicle). There were no differences in adverse events between alclometasone and tacrolimus (Phase I) or between tacrolimus and …
RESULTS: Of 206 randomly assigned patients, 152 completed Phase I; 105 of 152 were randomly assigned into Phase II (68 tacrolimus ointment a …
A phase II study (ARCHER 1042) to evaluate prophylactic treatment of dacomitinib-induced dermatologic and gastrointestinal adverse events in advanced non-small-cell lung cancer.
Lacouture ME, Keefe DM, Sonis S, Jatoi A, Gernhardt D, Wang T, Doherty JP, Giri N, Nadanaciva S, O'Connell J, Sbar E, Piperdi B, Garon EB. Lacouture ME, et al. Ann Oncol. 2016 Sep;27(9):1712-8. doi: 10.1093/annonc/mdw227. Epub 2016 Jun 10. Ann Oncol. 2016. PMID: 27287210 Free PMC article. Clinical Trial.
Cohort II patients received oral VSL#3 probiotic plus topical alclometasone. Primary end points for Cohorts I and II were incidence of all grade and grade 2 SDAEI in the first 8 weeks of treatment and quality of life (QoL) assessed by the Skindex-16 survey. ...CONCLUSIONS: …
Cohort II patients received oral VSL#3 probiotic plus topical alclometasone. Primary end points for Cohorts I and II were incidence o …
11 results

Searches related to "alclometasone"